In gastric cancer (GC), by targeting SLC34A2, the overexpression of miR-939 in GC cells significantly decreased Raf-1, p-MEK1/2 and p-ERK expression levels for suppressing the chemoresistance and metastasis of GC34. The gene discussed is SLC34A2; the disease is gastric cancer.